Liping Liu1, Midori A Yenari. 1. Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China.
Abstract
OBJECTIVE: Hypothermia has long been known to be a potent neuroprotectant. In this mini-review, we highlighted clinical experience that hypothermia protects the brain from cerebral injury. We discussed the clinical practice of hypothermia in ischemic stroke. RESULTS: Multiple factors play a significant role in the mechanisms. Clinical application drew first from two clinical trials with comatose patients after cardiac arrest is attractive. The Australian and European study have led to renewed interest in these patients. More and more evidences bring the insight into its effects on cerebral ischemia. The type of cooling technique to be used, the duration of cooling and speed of rewarming appear to be key factors in determining whether hypothermia is effective in preventing or mitigating neurological injury. Although until now, there are no clear therapeutic standards of the parameters in therapeutic hypothermia, it is well accepted that cooling should be initiated as soon as possible. By combining hypothermia with other neuroprotectants, it may be possible to enhance protective effects, reduce side effects and lengthen the maximum time. CONCLUSION: In addition to its neuroprotective properties, hypothermia may extend the therapeutic window for other neuroprotective treatment. Thus, combination therapies with neuroprotective, anti-inflammatory and thrombolytic agents are likely to be investigated in the clinical setting in the future.
OBJECTIVE:Hypothermia has long been known to be a potent neuroprotectant. In this mini-review, we highlighted clinical experience that hypothermia protects the brain from cerebral injury. We discussed the clinical practice of hypothermia in ischemic stroke. RESULTS: Multiple factors play a significant role in the mechanisms. Clinical application drew first from two clinical trials with comatosepatients after cardiac arrest is attractive. The Australian and European study have led to renewed interest in these patients. More and more evidences bring the insight into its effects on cerebral ischemia. The type of cooling technique to be used, the duration of cooling and speed of rewarming appear to be key factors in determining whether hypothermia is effective in preventing or mitigating neurological injury. Although until now, there are no clear therapeutic standards of the parameters in therapeutic hypothermia, it is well accepted that cooling should be initiated as soon as possible. By combining hypothermia with other neuroprotectants, it may be possible to enhance protective effects, reduce side effects and lengthen the maximum time. CONCLUSION: In addition to its neuroprotective properties, hypothermia may extend the therapeutic window for other neuroprotective treatment. Thus, combination therapies with neuroprotective, anti-inflammatory and thrombolytic agents are likely to be investigated in the clinical setting in the future.
Authors: A Zeiner; M Holzer; F Sterz; W Behringer; W Schörkhuber; M Müllner; M Frass; P Siostrzonek; K Ratheiser; A Kaff; A N Laggner Journal: Stroke Date: 2000-01 Impact factor: 7.914
Authors: A J Pazos; E J Green; R Busto; P M McCabe; R C Baena; M D Ginsberg; M Y Globus; N Schneiderman; W D Dietrich Journal: Brain Res Date: 1999-11-06 Impact factor: 3.252
Authors: D W Krieger; M A De Georgia; A Abou-Chebl; J C Andrefsky; C A Sila; I L Katzan; M R Mayberg; A J Furlan Journal: Stroke Date: 2001-08 Impact factor: 7.914
Authors: Stephen A Bernard; Timothy W Gray; Michael D Buist; Bruce M Jones; William Silvester; Geoff Gutteridge; Karen Smith Journal: N Engl J Med Date: 2002-02-21 Impact factor: 91.245
Authors: M M Ning; M Lopez; D Sarracino; J Cao; M Karchin; D McMullin; X Wang; F S Buonanno; E H Lo Journal: Neurol Res Date: 2013-06 Impact factor: 2.448